Different mechanisms are involved in the prothrombotic state of COVID-19 patients, including a dysregulated renin–angiotensin–aldosterone system (RAAS), endothelial dysfunction, elevated von Willebrand factor (vWF), and a dysregulated immune response. Here, REN is linked to endothelial dysfunction.